A detailed history of Virtu Financial LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 26,509 shares of PBYI stock, worth $71,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,509
Holding current value
$71,839
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$2.25 - $4.03 $59,645 - $106,831
26,509 New
26,509 $68,000
Q3 2023

Nov 14, 2023

BUY
$2.63 - $4.09 $37,509 - $58,331
14,262 New
14,262 $38,000
Q4 2022

Feb 15, 2023

BUY
$2.12 - $5.08 $105,491 - $252,780
49,760 New
49,760 $210,000
Q3 2021

Nov 12, 2021

SELL
$6.63 - $9.39 $135,145 - $191,405
-20,384 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$8.98 - $11.6 $183,048 - $236,454
20,384 New
20,384 $187,000
Q1 2021

May 19, 2021

SELL
$9.38 - $13.63 $152,077 - $220,983
-16,213 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$7.78 - $12.13 $126,137 - $196,663
16,213 New
16,213 $166,000
Q4 2019

Feb 04, 2020

SELL
$6.5 - $10.73 $69,140 - $114,135
-10,637 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$8.75 - $12.85 $93,073 - $136,685
10,637 New
10,637 $115,000
Q1 2019

Apr 12, 2019

SELL
$20.77 - $42.37 $354,440 - $723,044
-17,065 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$20.07 - $46.7 $342,494 - $796,935
17,065 New
17,065 $347,000
Q4 2017

Feb 09, 2018

SELL
$93.85 - $132.45 $517,958 - $730,991
-5,519 Closed
0 $0
Q3 2017

Nov 20, 2017

BUY
$72.0 - $119.75 $397,368 - $660,900
5,519
5,519 $661,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $123M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.